Why is New York suing Capital One?
How will new Social Security rules affect retirees?
What impact will ESPN’s new streaming app have?
Why is GSK investing heavily in liver disease drugs?
How did Trump’s Middle East trip boost AI deals?
What risks do proposed Medicaid cuts pose?
How will Canada’s delayed budget affect the economy?
Why did Amazon cut jobs in its devices unit?
What caused Foot Locker’s stock surge amid buyout talks?
Exelixis Stock Soars As Analysts Applaud Raised 2025 Guidance, Q1 Earnings Beat
benzinga.com/general/biotech/25/05/45418036/exelixis-stock-soars-as-analysts-applaud-raised-2025-guidance-q1-earnings-beat
Exelixis Inc. (NASDAQ:EXEL) on Tuesday reported its first quarter of 2025 adjusted earnings of 62 cents per share, compared to 17 cents a year ago, beating the consensus of 36 cents.
The cancer-focused company reported quarterly sales of $555.45 million, beating the consensus of $498.18…
This story appeared on benzinga.com, 2025-05-14 18:55:10.